Skip to main content

Advertisement

Table 1 Sociodemographic, comorbidities and biochemical characteristics of the study sample

From: Clinical malaria and the potential risk of anaemia among preschool-aged children: a population-based study of the 2015–2016 Malawi micronutrient survey

VariableFrequency
n = 1051
Percent
(%)
Sex
 Female53949.18
 Male51250.82
Age (months)
 6–11979.43
 12–2322121.77
 24–3525725.29
 36–4726424.00
 48–5921219.52
Fever in last 2 weeks
 Yes50543.25
 No54656.75
Malaria test result
 Positive27827.63
 Negative77372.37
Clinical malariaa
 Yes27127.37
 No78072.63
Alpha1-Acid Glycoprotein
 Normal44344.33
 Abnormal60855.67
Serum ferritinb
 Normal83578.29
 Abnormal21621.71
G6PD (n = 1004)
 Unaffected72372.08
 Affected11811.76
 Carrier16216.15
Alpha-thalassemia (n = 999)
 Unaffected60960.96
 Affected808.01
 Carrier31031.03
Household hunger scale
 Little to none48539.98
 Moderate to severe56660.02
Type of place of residence
 Urban11710.03
 Rural93489.97
Region of residence
 North37213.82
 Central38344.34
 Southern29641.84
Outcome variable
Any anemia
  < 110 g/L74270.96
  ≥ 110 g/L30929.04
  1. G6PD Glucose-6-phosphate dehydrogenase
  2. aDefined as an individual with malaria-related symptoms (fever [axillary temperature ≥ 37.5 °C], chills, severe malaise, headache or vomiting) at the time of examination or 1–2 days prior to the examination in the presence of a Plasmodium falciparum positive blood smear; bSerum ferritin adjusted for inflammation using internal regression approach, malaria test using a rapid diagnostic test (RDT) kit the Standard Diagnostic (SD) BIOLINE Malaria Ag P.f/Pan histamine-rich protein (HRP-II)™ RDT)